logo UCSF Benioff Children's Hospital Oakland
Hematology/Oncology Department
Research Studies Open for Enrollment
Date: 10/22/2018

Neuro-Oncology:

Title ID/Protocol NCT/Phase Sponsor P.I. Contact
Clinical/Molecular Risk-Tailored Intensive, Compressed Induction Chemotherapy Followed by Consolidation Randomization To Single-Cycle or 3 Tandem Cycles of Marrow-Ablative Chemo with Hematopoietic Progenitor Cell RescueHead-Start-4 NCT02875314
Phase 4
Next Consortium, Nationwide Children'sJoseph Torkildson, MDJoseph Torkildson, MD
Genomic Analysis in Pediatric MalignanciesGenomics N/A
N/ATabitha Cooney, MDTabitha Cooney, MD
H3.3.K27M specific peptide vaccine combined with poly-ILCL for the treatment of newly diagnosed HLA-A2+ H3.3K27M positive diffuse intrinsic pontine glioma and other newly diagnosed HLA-A2+ H3.3K27M positive gliomasPNOC007 NCT02960230
Phase 1
Pacific Pediatric Neuro-Oncology Consortium (PNOC)Tabitha Cooney, MDTabitha Cooney, MD (510-428-3885 x3398)
Phase 2 Study of everolimus for recurrent or progression low-grade gliomas in childrenPNOC001 NCT01734512
Phase 2
Pacific Pediatric Neuro-Oncology Consortium (PNOC)Joseph Torkildson, MDJoseph Torkildson, MD
Prospective multi-institutional study to assess the risk of radiation induced vasculopathy and stroke as well as stroke recurrence in children with cancer who received radiation therapy to the neck and/or brainRadART-Pro N/A
LaRoche FamilyJoseph Torkildson, MDJoseph Torkildson, MD

UCSF Benioff Children's Hospital Oakland • 747 52nd Street, Oakland, California 94609 • Phone: (510) 428-3000